Expression and clinical significance of the transforming growth factor-β signalling pathway in endometrial cancer

Histopathology

Volumn 59, Issue 1, 2011, Pages 63-72

  Mhawech Fauceglia, Paulette ^a   Kesterson, Joshua ^a   Wang, Dan ^a   Akers, Stacey ^a   Dupont, Nefertiti Chianti ^a   Clark, Kimberly ^a   Lele, Shashikant ^a   Liu, Song ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Endometrial cancer; MRNA level; Patient prognosis; Protein immunoexpression; TGF Smad signalling pathway

Indexed keywords

DISABLED 2 PROTEIN; MESSENGER RNA; ONCOPROTEIN; SKIL PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ABDOMINAL HYSTERECTOMY; ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER GRADING; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CANCER TISSUE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DOWN REGULATION; ENDOMETRIUM CANCER; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SALPINGOOOPHORECTOMY; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; AGED, 80 AND OVER; CELL LINE, TUMOR; DOWN-REGULATION; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MIDDLE AGED; PROGNOSIS; PROTO-ONCOGENE PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; SIGNAL TRANSDUCTION; SMAD PROTEINS; TRANSFORMING GROWTH FACTOR BETA;

EID: 79960456699     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2011.03892.x     Document Type: Article

References (28)

1. Jaowlew SB. Transforming growth factor-β in cancer and metastasis. Cancer Metastasis Rev. 2006; 25; 435-457.
2. Ikushima H, Miyazono K. TGFbeta signalling: a complex web in cancer progression. Nat. Rev. Cancer 2010; 10; 415-424.
3. Joshi A, Cao D. TGF-beta signaling, tumor microenvironment and tumor progression: the butterfly effect. Front. Biosci. 2010; 15; 180-194.
4. Moustakas A, Souchelnytskyl S, Heldin C-H. Smad regulation in TGF-β signal transduction. J. Cell Sci. 2001; 114; 4359-4369.
5. Deheuninck J, Luo K. Ski and SnoN, potent regulators of TGF β signaling. Cell Res. 2009; 19; 47-57.
6. Hocevar BA, Smine A, Xu X-X, Howe PH. The adaptor molecule Disabled-2 links the transforming factor β receptors to the Smad pathway. EMBO J. 2001; 20; 2789-2801.
7. Bravou V, Antonacopoulou A, Papadaki H et al. TGF β repressors SnoN and Ski are implicated in human colorectal carcinogenesis. Cell Oncol. 2009; 31; 41-51.
8. Mok SC, Chan WY, Wong KK et al. DOC-2, a candidate tumor suppressor gene in human epithelial ovarian cancer. Oncogene 1998; 16; 2381-2387.
9. Fazili Z, Sun W, Mittelstaedt S, Cohen C, Xu XX. Disabled-2 inactivation is an early step in ovarian tumorigenicity. Oncogene 1999; 18; 3104-3113.
10. Santin AD, Zhan F, Bellone S et al. Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: identification of candidate molecular markers for ovarian cancer diagnosis. Int. J. Cancer 2004; 112; 14-25.
11. Friedman E, Gold LI, Klimstra D, Zeng ZS, Winawer S, Cohen A. High levels of transforming growth factor-beta 1 correlate with disease progression in human colon cancer. Cancer Epidemiol. Biomarkers Prev. 1995; 4; 549-554.
12. Freiss H, Yamanaka Y, Buchler M et al. Enhanced expression of transforming growth factor beta isoforms in pancreatic cancer correlated with decreased survival. Gastroenterology 1993; 105; 1846-1856.
13. Fukai Y, Fukuchi M, Masuda N et al. Reduced expression of transforming growth factor-β receptors is an unfavorable prognostic factor in human esophageal squamous cell carcinoma. Int. J. Cancer 2003; 104; 161-166.
14. Rozenblum E, Schutte M, Goggins SA et al. Tumor-suppressive pathways in pancreatic carcinoma. Cancer Res. 1997; 57; 1731-1734.
15. Parekh TV, Gama P, Wen X et al. Transforming growth factor β signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition. Cancer Res. 2002; 62; 2778-2790.
16. Sakaguchi J, Kyo S, Kanaya T et al. Aberrant expression and mutations of TGF β receptor type II gene in endometrial cancer. Gynecol. Oncol. 2005; 98; 427-433.
17. Piestrzeniewicz-Ulanska D, Brys M, Semczuk A, Rechberger T, Jakowicki JA, Krajewska WM. TGF β signaling is disrupted in endometrioid-type endometrial carcinomas. Gynecol. Oncol. 2004; 95; 173-180.
18. Creasman WT. Revision in classification by International Federation of Gynecology and Obstetrics. Am. J. Obstet. Gynecol. 1992; 167; 857-858.
19. Hahn SA, Schutte M, Hoque AT et al. DPC4, a candidate tumor supressor gene at human chromosome 18q21.1. Science 1996; 271; 350-353.
20. Yang G, Yang X. Smad4-mediated TGFβ signaling in tumorigenesis. Int. J. Biol. Sci. 2010; 6; 1-8.
21. Miyaki M, Kuroki T. Role of Smad4 (DPC4) inactivation in human cancer. Biochem. Biophys. Res. Commun. 2003; 306; 799-804.
22. Kloth JN, Kenter GG, Spijker HS et al. Expression of Smad2 and Smad4 in cervical cancer: absent nuclear smad4 expression correlates with poor survival. Mod. Pathol. 2008; 21; 866-875.
23. Xie W, Mertens JC, Reiss DJ et al. Alterations of Smad signaling in human breast carcinoma are associated with poor outcome; a tissue microarray study. Cancer Res. 2002; 62; 497-505.
24. Alazzouzi H, Alhopuro P, Salovaara R et al. Smad4 as a prognostic marker in colorectal cancer. Clin. Cancer Res. 2005; 11; 2606-2611.
25. Gold LI. The role of transforming growth factor beta (TG-beta) in human cancer. Crit. Rev. Oncog. 1999; 10; 303-360.
26. Anupam K, Tusharkant C, Gupta SD, Ranju R. Loss of disabled-2 expression is an early event in esophageal squamous tumorigenesis. World J. Gastroenterol. 2006; 12; 6041-6045.
27. Bagadi SAR, Prasad CP, Srivastava A, Prashad R, Gupta SD, Ralhan R. Frequent loss of Dab2 protein and infrequent promotor hypermethylation in breast cancer. Breast Cancer Res. Treat. 2007; 104; 277-286.
28. Fukuchi M, Nakajima M, Fukai Y et al. Increased expression of c-Ski as a co-repressor in transforming growth factor-beta signaling correlates with progression of esophageal squamous cell carcinoma. Int. J. Cancer 2004; 108; 818-824.